LACTB inhibits phosphatidylserine decarboxylase and reduces the abundance of phosphatidylethanolamine and lyso-phosphatidylethanolamine, leading to a mitochondrial state compatible with tumor suppression, decreased proliferation, and enhanced differentiation. Here, LACTB is linked to neoplasm.